| Quarter (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 20 |
| Opened positions | 6 |
| Closed positions | 2 |
| Increased positions | 5 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 19.99 bn |
| Total shares | 31.24 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| JSR | 5.34 mm | $0.00 |
| WuXi PharmTech Healthcare Fund I | 5.28 mm | $42.62 mm |
| Huang James | 4.01 mm | $12.65 mm |
| General Atlantic | 3.83 mm | $7.61 bn |
| FIL | 3.27 mm | $6.39 bn |
| Smith Vincent C | 3.13 mm | $5.78 mm |
| Panacea Innovation | 3.04 mm | $5.62 mm |
| SC CHINA HOLDING | 1.34 mm | $2.38 bn |
| FMR | 1.29 mm | $2.52 bn |
| Mill Creek Capital Advisors | 199.61 k | $397.22 mm |
